510(k) K181556
K181556 is an FDA 510(k) premarket notification submitted by Phadia AB for the device "EliA M2 Immunoassay". The FDA issued a decision of Substantially Equivalent on July 13, 2018. The device falls under product code DBM (Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control), a Class II device regulated under 21 CFR 866.5090. Phadia AB has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 13, 2018
- Date Received
- June 13, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control
- Device Class
- Class II
- Regulation Number
- 866.5090
- Review Panel
- IM
- Submission Type